Drug Trial Radar · NCT05254171
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Last checked: Nov 19, 2026Latest source record: Nov 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
600
Planned (sponsor's estimate)
Start
Aug 8, 2022
Primary completion
Aug 29, 2026
Study completion Jan 1, 2027
Sponsor
- Lead sponsor
- Panbela Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 24, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is a randomized, double-blind, placebo-controlled, multicenter study of standard treatment with nab-paclitaxel and gemcitabine with or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have received prior neoadjuvant or adjuvant treatment.
Conditions
- Pancreatic Cancer Metastatic
- Pancreatic Ductal Adenocarcinoma
- Pancreatic Cancer Stage IV
Interventions
SBP-101Drug
small molecule polyamine metabolic inhibitor for subcutaneous injection
Nab-paclitaxelDrug
paclitaxel protein-bound particles for injectable suspension
GemcitabineDrug
gemcitabine for injection
PlaceboOther
Normal Saline
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival (OS)Time frame: From date of first dose up to 100 weeks or until death
Locations
93 sites in 10 countries. Site status is shown where the registry gives one.
Genesis Cancer and Blood Institute (SCRI)
Hot Springs, Arkansas · Withdrawn
Providence Medical Foundation
Fullerton, California · Recruiting
Yale Cancer Center
New Haven, Connecticut · Recruiting
MedStar Georgetown University Hospital
Washington D.C., District of Columbia · Active not recruiting
Henry Ford Health System
Detroit, Michigan · Recruiting
CentraCare Health
Saint Cloud, Minnesota · Withdrawn
Columbia University Medical Center
New York, New York · Recruiting
University of Rochester
Rochester, New York · Recruiting
Mark H Zangmeister Center - SCRI - PPDS
Columbus, Ohio · Terminated
Tennessee Oncology NASH - SCRI - PPDS
Nashville, Tennessee · Active not recruiting
HOPE Cancer Center of East Texas
Tyler, Texas · Recruiting
Medical Oncology Associates - Spokane
Spokane, Washington · Recruiting
MultiCare Regional Cancer Center - Tacoma
Tacoma, Washington · Recruiting
Froedtert Hospital & the Medical College of Wisconsin
Milwaukee, Wisconsin · Recruiting
Canberra Region Cancer Centre
Garran, Australia Capital Territory, Australia · Recruiting
The Tweed Hospital
Tweed Heads, New South Wales, Australia · Withdrawn
Ashford Cancer Centre Research
Kurralta Park, South Australia, Australia · Recruiting
Austin Hospital
Heidelberg, Victoria, Australia · Recruiting
St John of God Murdoch Hospital
Murdoch, Western Australia, Australia · Recruiting
Kepler Universitätsklinikum Linz
Linz, Austria · Recruiting
Salzburg Cancer Research Institute
Salzburg, Austria · Active not recruiting
A.ö. Krankenhaus der Barmherzigen Brüder
Wein, Austria · Recruiting
Landesklinikum Wiener Neustadt
Wiener Neustadt, Austria · Recruiting
Klinikum Klagenfurt Am Woerthersee
Klagenfurt, Carinthia, Austria · Recruiting
Universitätsklinikum St. Pölten
Sankt Pölten, Lower Austria, Austria · Recruiting
Ordensklinikum Linz, Krankenhaus der Barmherzigen Schwestern Linz Betriebsgesellschaft m.b.H
Linz, Upper Austria, Austria · Not yet recruiting
Pyhrn-Eisenwurzen Klinikum Steyr
Steyr, Upper Austria, Austria · Withdrawn
Klinikum Wels-Grieskirchen GmbH
Wels, Upper Austria, Austria · Recruiting
Landeskrankenhaus Feldkirch
Rankweil, Vorarlberg, Austria · Recruiting
Grand Hopital de Charleroi asbl
Charleroi, Belgium · Recruiting
UZ Leuven
Leuven, Belgium · Recruiting
CHU de Liège
Liège, Belgium · Recruiting
Imelda VZW
Bonheiden, Antwerpen, Belgium · Recruiting
Cliniques Universitaires Saint-Luc
Brussels, Belgique, Belgium · Not yet recruiting
Hôpital de Jolimont
La Louvière, Hainaut, Belgium · Recruiting
Centre Hospitalier de l'Ardenne
Libramont, Luxembourg, Belgium · Recruiting
CHU UCL Namur asbl - Site Godinne
Yvoir, Namur, Belgium · Recruiting
Onze-Lieve-Vrouwziekenhuis
Aalst, Oost-Vlaanderen, Belgium · Recruiting
UZ Gent
Ghent, Oost-Vlaanderen, Belgium · Recruiting
AZ Groeninge
Kortrijk, West-Vlaanderen, Belgium · Recruiting
Showing 40 of 93 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.